文献速递脑血管病外科神经重症

卒中相关的阵发性交感神经过度兴奋

Paroxysmal Sympathetic Hyperactivity in Stroke.
PubMed 文献 · World Neurosurg · 2023-07-07

该研究报道一例动脉瘤性蛛网膜下腔出血(aSAH)后阵发性交感神经过度兴奋(PSH)病例,并检索PubMed 1980至2021年文献纳入19篇文献共25例卒中相关PSH病例。队列中男性15例(60.0%),平均年龄40.1±16.6岁,PSH发病中位时间为入院后5(1-180)天,格拉斯哥结局量表仅1例(5.3%)恢复良好。作者认为aSAH后PSH的临床特征和治疗不同于aSAH相关高肾上腺素能危象,早期诊断和治疗可预防严重并发症。

要点

  • 卒中相关PSH队列原发诊断以颅内出血13例(52.0%)最多,脑梗死7例(28.0%)、蛛网膜下腔出血4例(16.0%)、脑室内出血1例(4.0%)。
  • PSH发病中位时间为入院后5(1-180)天,多数病例采用镇静药、β受体阻滞剂、加巴喷丁和可乐定联合治疗。
  • 格拉斯哥结局量表显示死亡4例(21.1%)、植物状态2例(10.5%)、严重残疾7例(36.8%)、恢复良好仅1例(5.3%)。

核心结论

  • aSAH后PSH的临床特征和治疗不同于aSAH相关高肾上腺素能危象。
  • 早期诊断和治疗可预防严重并发症,PSH应被认识为aSAH的潜在并发症。
  • 鉴别诊断有助于制定个体化治疗方案并改善患者预后。

研究设计与样本

  • 研究报道一例aSAH后PSH病例,并通过检索PubMed数据库1980至2021年文献识别19篇关于卒中相关PSH的文章(25例)。

主要发现

  • 总队列中男性15例(60.0%),平均年龄40.1±16.6岁。
  • 原发诊断包括颅内出血13例(52.0%)、脑梗死7例(28.0%)、蛛网膜下腔出血4例(16.0%)、脑室内出血1例(4.0%)。
  • 卒中损伤部位以大脑叶10例(40.0%)、基底节8例(32.0%)、脑桥4例(16.0%)为主。
  • PSH发病中位时间为入院后5(1-180)天。
  • 格拉斯哥结局量表结局包括死亡4例(21.1%)、植物状态2例(10.5%)、严重残疾7例(36.8%)、恢复良好1例(5.3%)。

临床怎么用

  • 多数病例采用镇静药、β受体阻滞剂、加巴喷丁和可乐定联合治疗。
  • 作者认为早期诊断和治疗可预防严重并发症。
  • 作者认为鉴别诊断有助于制定个体化治疗方案并改善患者预后。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Paroxysmal sympathetic hyperactivity (PSH) is a life-threatening neurological emergency associated with severe brain injury. Stroke-related PSH, particularly post-aneurysmal subarachnoid hemorrhage (aSAH) PSH, has been relatively understudied and is often misdiagnosed as an aSAH-related hyperadrenergic crisis. This study aims to clarify the feature of stroke-related PSH. METHODS: This study discusses the case of a patient with post-aSAH PSH and identifies 19 articles (25 cases) on stroke-related PSH by searching the PubMed database from 1980 to 2021. RESULTS: In the total cohort, 15 (60.0%) patients were male and the average age was 40.1 ± 16.6 years. The primary diagnoses included intracranial hemorrhage (13 cases, 52.0%), cerebral infarction (7 cases, 28.0%), subarachnoid hemorrhage (4 cases, 16.0%), and intraventricular hemorrhage (1 case, 4.0%). The sites of stroke damage were predominantly the cerebral lobe (10 cases, 40.0%), basal ganglia (8 cases, 32.0%), and the pons (4 cases, 16.0%). The median time of PSH onset after admission was 5 (1-180) days. Most cases employed combination therapy with sedation drugs, beta-blockers, gabapentin, and clonidine. On the Glasgow Outcome Scale, outcomes included death (4 cases, 21.1%), vegetative state (2 cases, 10.5%), severe disability (7 cases, 36.8%), and in only one case (5.3%) was a good recovery noted. CONCLUSIONS: The clinical features and treatment of post-aSAH PSH differed from those of aSAH-related hyperadrenergic crises. Early diagnosis and treatment can prevent severe complications. PSH should be acknowledged as a potential complication of aSAH. Differential diagnosis can aid in developing individualized treatment plans and improving patient prognosis.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Muraoka S, Kumagai Y, Koketsu N, et al. Paroxysmal Sympathetic Hyperactivity in Stroke. World Neurosurg. 2023. PMID: 37423330. doi:10.1016/j.wneu.2023.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。